Industry Demands Rethink Of German HTA Data Requirements
Executive Summary
The pharmaceutical industry is calling for more flexible evidence requirements for health technology assessments in Germany after the country’s HTA body, IQWiG, claimed that too many new products entering the market lack additional benefit.